Stock buzz with Nikunj Dalmia: Natco Pharma
Natco Pharma, the first company to file for Revlimid generic, may go ahead with ‘at risk’ launch of Copaxone. Analysts see short-term upside for the stock.
Other Stocks Videos
Biocon to sell stake in biosimilar arm and Syngene: Sources
Stocks in news: Lupin, GMR Airports and more
Stocks in news: United Breweries, Tata Motors, Mazagon Dock and more
Manipal's Ranjan Pai acquires Rs 1,400 crore Davidson Kempner debt on BYJU's
Samvat 2080: 80 stock recommendations from top brokerage houses for your portfolio this new year
